Suboxone Recovery Program

Suboxone Treatment in Albany, NY

Suboxone is one of the most widely used and clinically effective medications for opioid use disorder, a proven MAT option that reduces cravings, manages withdrawal symptoms, and provides the physiological stability that makes recovery possible. At Fusion Recovery Center in Albany, NY, our Suboxone treatment program is delivered by board-certified physicians and integrated with individual therapy, group counseling, and structured outpatient programming from day one. Whether you are beginning treatment for opioid dependency or transitioning from a higher level of care, Suboxone may be the clinical foundation your recovery needs.

suboxone-banner-image

What Is Suboxone and How Does It Work?

Suboxone is an FDA-approved medication containing two active components, buprenorphine and naloxone, that work together to treat opioid use disorder.

  • Buprenorphine is a partial opioid agonist. It attaches to the same brain receptors as opioids but activates them only partially, producing a stabilizing effect without the intense euphoric high of full opioid agonists. This reduces cravings and eases withdrawal symptoms while significantly lowering the risk of misuse or overdose compared to full agonist medications.
  • Naloxone is an opioid antagonist. It blocks opioid receptors and is included in Suboxone specifically to deter misuse. If Suboxone is taken as directed sublingually (dissolved under the tongue), the naloxone has minimal effect. If it is injected or misused, the naloxone activates and blocks any opioid effect, creating a strong deterrent against diversion and misuse.
Together, these components make Suboxone one of the safest and most misuse-resistant MAT options available for opioid use disorder. It is typically administered as a daily sublingual film or tablet, dissolved under the tongue.

What to Expect: Suboxone Treatment at Fusion Recovery

01.

Comprehensive Clinical Evaluation

Your treatment begins with a full clinical evaluation, a physical exam, a complete review of your substance use history, mental health screening, and assessment of any co-occurring conditions. This evaluation shapes your entire treatment plan, including the appropriate starting dose of Suboxone and the clinical services most relevant to your recovery. Your clinical team will also determine whether Suboxone, or another MAT medication, is the best fit for your specific situation.

02.

Stabilization

Suboxone induction, the process of starting the medication, is carefully timed and managed by your clinical team. Because buprenorphine is a partial agonist, it must be initiated when you are in mild to moderate withdrawal; starting too early can precipitate more severe withdrawal symptoms. Your physician will guide you through this process, monitoring symptoms closely and adjusting the dose until you reach stability, the point at which cravings and withdrawal are well-controlled.

03.

Maintenance Treatment

Once stabilized, you enter the maintenance phase,taking your prescribed dose of Suboxone daily while engaging in the counseling, therapy, and outpatient programming that form the behavioral foundation of recovery. Unlike methadone, Suboxone can be prescribed for home use by a certified prescriber, meaning daily clinic visits are not required after the initial stabilization period.

04.

Integrated Counseling and Therapy

Throughout Suboxone alone is not recovery. At Fusion Recovery, Suboxone treatment is integrated with individual therapy, group counseling, and structured outpatient programming from the start. Your therapist works alongside your prescribing physician to ensure that the medical and clinical dimensions of your care are fully coordinated, addressing the root causes of your addiction alongside the physiological stabilization the medication provides.

05.

Tapering

For patients whose recovery goals include discontinuing Suboxone, a gradual taper is planned collaboratively with your clinical team. As with methadone, tapering is always done slowly and carefully, never abruptly,  to minimize withdrawal and support the transition to a Suboxone-free state when clinically appropriate. For some patients, long-term maintenance is the right clinical decision; for others, a planned taper is the goal. Both are valid, and both are managed with the same clinical care.

Who Is Suboxone Treatment For?

Suboxone is indicated for opioid use disorder and is most appropriate for:

Patients with opioid dependency seeking outpatient treatment

Suboxone’s home-based dosing model makes it well-suited for patients who cannot or do not want to attend a daily clinic. It provides effective opioid stabilization within a flexible outpatient framework.

Patients transitioning from detox

Suboxone is commonly initiated during or immediately after medical detox, bridging stabilization directly into maintenance treatment and ongoing recovery programming.

Patients seeking a less restrictive MAT option than methadone

Unlike methadone, which requires daily supervised dosing at an OTP-certified clinic, Suboxone can be prescribed by any certified physician for take-home use, offering more flexibility and privacy for patients who need or prefer it.

Patients with moderate opioid dependency

Suboxone’s partial agonist mechanism is highly effective for many patients with opioid use disorder. For patients with very high-tolerance or severe physical dependency, methadone’s full agonist mechanism may provide stronger stabilization, your clinical team will help determine the right fit.

Patients concerned about misuse potential

The naloxone component in Suboxone significantly reduces misuse potential compared to methadone or buprenorphine alone, making it a preferred option for patients or prescribers with concerns about diversion or misuse risk.

Suboxone vs. Methadone: Understanding the Difference

Both Suboxone and methadone are effective MAT options for opioid use disorder and are available at Fusion Recovery. The right choice depends on your clinical history, the severity of your dependency, and your treatment preferences.

Suboxone

Mechanism

Partial opioid agonist + naloxone

Administration

Daily sublingual film or tablet

Prescribing setting

Certified physician — home use available

Misuse potential

Lower — naloxone deters misuse

Best for

Moderate dependency, flexible outpatient

Take-home doses

Available from outset with prescriber

Mechanism

Full opioid agonist

Administration

Daily supervised clinic dose (initially)

Prescribing setting

OTP-certified clinic required

Misuse potential

Higher — closely monitored

Best for

Significant dependency, prior treatment attempts

Take-home doses

Available after demonstrated stability

Why Choose Fusion Recovery for Suboxone Treatment in New York?

Fusion Recovery brings together the clinical expertise, integrated care approach, and compassionate environment that effective Suboxone treatment requires — all within a flexible outpatient program in Albany, NY.

 

  • Board-certified physicians managing Suboxone prescribing, dosing, and medical oversight
  • Counseling integrated from day one — individual therapy, group therapy, and structured programming alongside medication
  • Personalized treatment plans built around your full clinical picture
  • Flexible outpatient scheduling — Suboxone’s home-based dosing model fits around work, family, and daily life
  • Non-judgmental, stigma-free environment — compassionate care regardless of history
  • OASAS-certified outpatient treatment provider serving Albany and the Capital Region

Start Suboxone Treatment at Fusion Recovery

If you’re ready to begin Suboxone treatment — or if you have questions about whether it’s the right option for your situation — our clinical team is here to help.

Suboxone Frequently Asked Questions

01. What is Suboxone and what is it used for?

Suboxone is an FDA-approved medication containing buprenorphine and naloxone, used to treat opioid use disorder. Buprenorphine is a partial opioid agonist that reduces cravings and withdrawal symptoms; naloxone is an antagonist included to deter misuse. At Fusion Recovery, Suboxone is prescribed as part of a comprehensive MAT program that includes counseling and structured outpatient care.

Buprenorphine, the active component in Suboxone, has a long half-life. In most patients, it can be detected in urine for up to 7–10 days after the last dose. Complete elimination typically occurs within 5–8 days (120–210 hours) in healthy patients, though this varies based on dosage, frequency, metabolism, and individual physiology.

In opioid-dependent patients taking Suboxone at therapeutic doses, it does not produce a euphoric high — it stabilizes opioid receptors without the intense effects of full agonists. The naloxone component further deters misuse. In opioid-naive individuals, buprenorphine can produce opioid-like effects at high doses, which is why it is prescribed only under medical supervision as part of a clinical treatment program.

Neither is universally better — clinical appropriateness depends on the individual. Suboxone offers more flexibility (home-based dosing, no clinic requirement) and lower misuse potential. Methadone is a full opioid agonist that may provide stronger stabilization for patients with severe dependency. Your clinical team at Fusion Recovery will help determine which option best fits your history and recovery goals.

Yes. Most insurance plans, including Medicaid, cover Suboxone as part of substance use disorder treatment. Fusion Recovery accepts a wide range of insurance plans and can verify your specific benefits before your first appointment.

Suboxone’s buprenorphine component attaches to opioid receptors in the brain and partially activates them — reducing cravings and withdrawal symptoms without producing the euphoric high of full opioid agonists. This stabilizes brain chemistry and removes the physiological pull of active opioid use, giving patients the stability to engage in the behavioral work of recovery.

At standard therapeutic doses, Suboxone’s buprenorphine component provides 24 hours or more of opioid receptor occupancy — effectively blocking the effects of other opioids for the duration of the daily dose. This is one of the key protective mechanisms of Suboxone treatment.

Contact our admissions team by phone or through our website. We’ll walk you through the intake process, conduct a comprehensive clinical evaluation, verify your insurance coverage, and determine whether Suboxone is the most appropriate MAT option for your situation. If Suboxone is indicated, your physician will guide you through induction and the transition to maintenance treatment.

The appropriate duration of Suboxone treatment is determined by individual clinical need. Many patients benefit from longer-term maintenance; others work with their clinical team toward a planned taper. There is no clinical evidence supporting a time limit — the goal is sustained recovery, and the timeline is shaped by your progress and goals.

Completing or tapering off Suboxone is a significant milestone in recovery — and Fusion Recovery ensures you don’t face it without support. Before any taper is completed, your clinical team builds a structured aftercare plan with you, including continued outpatient support, community resources, and a clear roadmap for maintaining sobriety after active medication treatment ends.

01. What is Suboxone and what is it used for?

Sublocade is an FDA-approved, extended-release injectable formulation of buprenorphine used to treat opioid use disorder. It is administered as a once-monthly subcutaneous injection by a healthcare provider, delivering consistent buprenorphine levels throughout the month without requiring daily patient dosing. At Fusion Recovery, Sublocade is available as part of a comprehensive MAT program integrated with counseling and outpatient care.

Suboxone’s buprenorphine component attaches to opioid receptors in the brain and partially activates them — reducing cravings and withdrawal symptoms without producing the euphoric high of full opioid agonists. This stabilizes brain chemistry and removes the physiological pull of active opioid use, giving patients the stability to engage in the behavioral work of recovery.

Buprenorphine, the active component in Suboxone, has a long half-life. In most patients, it can be detected in urine for up to 7–10 days after the last dose. Complete elimination typically occurs within 5–8 days (120–210 hours) in healthy patients, though this varies based on dosage, frequency, metabolism, and individual physiology.

At standard therapeutic doses, Suboxone’s buprenorphine component provides 24 hours or more of opioid receptor occupancy — effectively blocking the effects of other opioids for the duration of the daily dose. This is one of the key protective mechanisms of Suboxone treatment.

In opioid-dependent patients taking Suboxone at therapeutic doses, it does not produce a euphoric high — it stabilizes opioid receptors without the intense effects of full agonists. The naloxone component further deters misuse. In opioid-naive individuals, buprenorphine can produce opioid-like effects at high doses, which is why it is prescribed only under medical supervision as part of a clinical treatment program.

Contact our admissions team by phone or through our website. We’ll walk you through the intake process, conduct a comprehensive clinical evaluation, verify your insurance coverage, and determine whether Suboxone is the most appropriate MAT option for your situation. If Suboxone is indicated, your physician will guide you through induction and the transition to maintenance treatment.

Neither is universally better — clinical appropriateness depends on the individual. Suboxone offers more flexibility (home-based dosing, no clinic requirement) and lower misuse potential. Methadone is a full opioid agonist that may provide stronger stabilization for patients with severe dependency. Your clinical team at Fusion Recovery will help determine which option best fits your history and recovery goals.

The appropriate duration of Suboxone treatment is determined by individual clinical need. Many patients benefit from longer-term maintenance; others work with their clinical team toward a planned taper. There is no clinical evidence supporting a time limit — the goal is sustained recovery, and the timeline is shaped by your progress and goals.

Yes. Most insurance plans, including Medicaid, cover Suboxone as part of substance use disorder treatment. Fusion Recovery accepts a wide range of insurance plans and can verify your specific benefits before your first appointment.

Completing or tapering off Suboxone is a significant milestone in recovery — and Fusion Recovery ensures you don’t face it without support. Before any taper is completed, your clinical team builds a structured aftercare plan with you, including continued outpatient support, community resources, and a clear roadmap for maintaining sobriety after active medication treatment ends.

If you’re ready, we’ll listen and help you explore treatment options without pressure.

Take the first step

Providing hope to all. Compassionate outpatient care for our community.
Ready to talk?

Recovery begins when you reach out. Questions?
Call anytime to speak with an Admissions
Specialist, or request a consultation and we’ll follow up.

David Sietz, M.D.

Chief Medical Officer, Fusion Recovery

Email us or Call

Contact Form

"(Required)" indicates required fields

01. –– Your name(Required)
Scroll to Top

Privacy Overview

Fusion

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.